Comparison of antivascular endothelial growth factor treatment for myopia choroidal neovascularisation: a systematic review and meta-analysis of randomised controlled trials

OBJECTIVES: To evaluate the efficacy and safety of anti-vascular endothelial growth factor (anti-VEGF) therapy for myopia choroidal neovascularisation (CNV), and to compare the efficacy of two different anti-VEGF retreatment criteria. DATA SOURCES: PubMed, EMBASE, the Cochrane Library and ClinicalTr...

Descripción completa

Detalles Bibliográficos
Autores principales: Dong, Liming, Li, Guangyao, Song, Zhihui, Cheng, Xiao, Bai, Jie, Zhang, Chao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Ophthalmology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10360440/
https://www.ncbi.nlm.nih.gov/pubmed/37474162
http://dx.doi.org/10.1136/bmjopen-2022-067921

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10360440/
https://www.ncbi.nlm.nih.gov/pubmed/37474162
http://dx.doi.org/10.1136/bmjopen-2022-067921

Ejemplares similares